As cargo theft increases and qualified carrier capacity continues to decline, pharmaceutical supply chains are facing a new reality. GDP-certified transportation is no longer optional. It has become essential.
Over the past year, regulatory enforcement has tightened across the industry. Stricter CDL requirements and higher compliance standards have reduced the number of eligible drivers and carriers. What was once a broader pool of transportation options is now significantly more limited, especially for high-value and temperature-sensitive shipments.
At the same time, cargo theft has become more targeted and advanced. Recent data from the 2025 Verisk CargoNet Annual Analysis shows that total losses reached nearly $725 million in 2025. This increase was not driven by a sharp rise in incident volume, but by a shift toward high-value freight. Organized groups are focusing on shipments that offer greater returns, which places pharmaceutical products at higher risk during transit.
These trends create a challenging environment. Shippers are managing reduced capacity while facing greater exposure to theft and disruption. In this environment, not all carriers are equipped to handle the demands of pharmaceutical logistics.
GDP-certified transportation plays a critical role in ensuring that products are handled under strict quality standards, including temperature control, security protocols, and full traceability throughout the supply chain. This is where many supply chains unknowingly introduce risk—by relying on capacity that cannot meet evolving GDP and security standards.
As the pool of qualified carriers continues to shrink, access to GDP-accredited capacity is becoming increasingly limited. Companies that rely on general freight solutions face greater risk, while those that prioritize GDP-certified networks are better positioned to protect product integrity and patient safety.
Recent developments in industry standards further reinforce this shift. GDP accreditation, introduced in 2025, represents a significant step forward in establishing consistent quality and handling standards across road freight, and Tucker Company Worldwide was among the first five companies to achieve this accreditation.
If your pharmaceutical shipments require uncompromising compliance, security, and control, now is the time to reassess your transportation strategy. Tucker Company Worldwide partners with shippers to identify risks, secure
qualified GDP capacity, and implement the standards that high-value freight demands.
Let’s evaluate your current network and ensure it’s built to protect what matters most.
